0000950170-24-078682.txt : 20240627 0000950170-24-078682.hdr.sgml : 20240627 20240627190124 ACCESSION NUMBER: 0000950170-24-078682 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240627 FILED AS OF DATE: 20240627 DATE AS OF CHANGE: 20240627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thomas Stephen Basil CENTRAL INDEX KEY: 0002027962 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40708 FILM NUMBER: 241080863 MAIL ADDRESS: STREET 1: 2525 SMITH STREET CITY: SCOTCH PLAINS STATE: NJ ZIP: 07076 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eliem Therapeutics, Inc. CENTRAL INDEX KEY: 0001768446 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 832273741 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2801 CENTERVILLE ROAD 1ST FLOOR STREET 2: PMB #117 CITY: WILMINGTON STATE: DE ZIP: 19808 BUSINESS PHONE: 877-354-3689 MAIL ADDRESS: STREET 1: 2801 CENTERVILLE ROAD 1ST FLOOR STREET 2: PMB #117 CITY: WILMINGTON STATE: DE ZIP: 19808 3 1 ownership.xml 3 X0206 3 2024-06-27 1 0001768446 Eliem Therapeutics, Inc. ELYM 0002027962 Thomas Stephen Basil C/O ELIEM THERAPEUTICS, INC. PMB #117, 2801 CENTERVILLE ROAD 1ST FLOOR WILMINGTON DE 19808 true false false false Exhibit Index: 24.1 - Power of Attorney /s/ Emily Pimblett, Attorney-in-Fact 2024-06-27 EX-24.1 2 ck0001768446-ex24_1.htm EX-24.1 EX-24.1

Exhibit 24.1

 

POWER OF ATTORNEY

 

Know all by these presents that the undersigned hereby constitutes and appoints each of Emily Pimblett and Andrew Levin, signing individually, the undersigned’s true and lawful attorneys-in fact and agents to:

 

(1)
prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the Securities and Exchange Commission (the “SEC”) a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation thereunder;

 

(2)
prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the SEC Forms 3, 4 and 5 (including amendments thereto and joint filing agreements in connection therewith) in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

 

(3)
do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to prepare and execute any such Form 3, 4 or 5 (including amendments thereto and joint filing agreements in connection therewith) and file such Forms with the SEC and any stock exchange, self-regulatory association or any other authority; and

 

(4)
take any other action of any type whatsoever in connection with the foregoing that, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required of the undersigned, it being understood that the documents executed by the attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as the attorney-in-fact may approve in the attorney-in-fact’s discretion.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, and their substitutes, in serving in such capacity at the request of the undersigned, are not assuming (nor is Eliem Therapeutics, Inc. (the “Company”) assuming) any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date written below.

 

Dated:

June 25, 2024

 

 

 

 

 

 

 

 

 

 

 

 

 

By:

/s/ Stephen Thomas

 

Stephen Thomas

 

 

 

Signature

 

 

Printed Name